Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.
Clinical Cancer Research.
Times cited: 65
A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations.
Journal of Thoracic Oncology.
Times cited: 69
Use of epidermal growth factor receptor/kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: Comparison with clinical guidelines.
Times cited: 60